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Although recent reports have described multipotent,
self-renewing, neural crest-derived stem cells
(NCSCs), the NCSCs in various adult rodent tissues
have not been well characterized or compared.
Here we identified NCSCs in the bone marrow (BM),
dorsal root ganglia, and whisker pad and prospec-
tively isolated them from adult transgenic mice
encoding neural crest-specific P0-Cre/Floxed-EGFP
and Wnt1-Cre/Floxed-EGFP. Cultured EGFP-posi-
tive cells formed neurosphere-like structures that
expressed NCSC genes and could differentiate into
neurons, glial cells, and myofibroblasts, but the
frequency of the cell types was tissue source depen-
dent. Interestingly, we observed NCSCs in the aorta-
gonad-mesonephros region, circulating blood, and
liver at the embryonic stage, suggesting that NCSCs
migrate through the bloodstream to the BM and
providing an explanation for how neural cells are
generated from the BM. The identification of NCSCs
in accessible adult tissue provides a new potential
source for autologous cell therapy after nerve injury
or disease.
INTRODUCTION
The neural crest is a transient embryonic tissue that originates at
the neural folds during vertebrate development. Neural crest
cells delaminate from the dorsal neural tube and migrate to var-
ious locations, where they differentiate into a vast range of cells,
including neurons and glial cells of the autonomic and enteric
nervous systems, smooth muscle cells of the heart and great
vessels, and bone and cartilage cells of the face (Le Douarin
and Kalcheim, 1999).
From theembryonicperiod throughadulthood,neural crest cells
are generated by neural crest-derived stem cells (NCSCs), which392 Cell Stem Cell 2, 392–403, April 2008 ª2008 Elsevier Inc.areself-renewingandmultipotent,with thepotential todifferentiate
into neurons, glial cells, and myofibroblasts (Morrison et al., 1999;
Shah et al., 1996). NCSCs have been isolated from the embryonic
sciatic nerve (Morrison et al., 1999) and boundary cap (BC) (Hjerl-
ing-Leffler et al., 2005) and the gut (Kruger et al., 2002), skin (Fer-
nandes et al., 2004; Sieber-Blum et al., 2004; Wong et al., 2006),
heart (Tomita et al., 2005), andcornea (Yoshidaetal., 2006) of adult
rodents. These reports demonstrate the presence of NCSCs in
these tissues and suggest their existence in other adult tissues.
Several types of stem cells have been identified in adult
tissues. For example, several groups have describedmultipotent
stem cells in the bonemarrow (BM), but the developmental origin
and differentiation potential of these cells are unknown (D’Ippo-
lito et al., 2004; Jiang et al., 2002; Ross et al., 2006). These stem
cells are reported to generate neural cells and smooth muscle
cells, which are known to originate from neural crest cells.
Such observations led us to investigate whether some newly
identified stem cells might be NCSCs.We examined this hypoth-
esis by investigating various tissues of double-transgenic mice
encoding Protein-0 (P0) and Wnt1 promoter-Cre/Floxed-EGFP,
in which neural crest-derived cells express EGFP (Danielian
et al., 1998; Kawamoto et al., 2000; Yamauchi et al., 1999).
Here, we prospectively isolated and compared neural crest-
derived stem and progenitor cells from the BM of the lower
extremities, dorsal root ganglia (DRG), and whisker pad (WP) of
adult P0 and Wnt1 promoter-Cre/Floxed-EGFP mice. This is
the first report identifying NCSCs in the BM of adult rodents.
The existence of NCSCs was confirmed in all three tissues,
and distinct differences among the NCSCs were revealed by
comparing their proliferation capacity, differentiation potential,
and gene expression profiles.
RESULTS
Distribution of EGFP-Positive Neural Crest-Lineage
Cells in Embryonic and Adult P0 and
Wnt1-Cre/Floxed-EGFP Mice
To examine the distribution of neural crest-derived cells
in various tissues, we performed histological analyses of
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Ontogeny and Multipotency of Neural Crest CellsP0-Cre/Floxed-EGFP mouse embryos and adults. P0 was origi-
nally identified as a Schwann cell-specific myelin protein (Lemke
et al., 1988), but it is also expressed by migrating neural crest
cells during the early embryonic period in chicks (Bhattacharyya
et al., 1991). In this transgenic mouse, the transient activation of
the P0 promoter induces Cre-mediated recombination, indelibly
tagging neural crest-derived cells with EGFP expression
(Kawamoto et al., 2000; Yamauchi et al., 1999). At E10.5,
EGFP was observed in the pharyngeal arches, periocular region,
and front nasal region, which contain neural crest-derived cells
(Figure 1A) (Yamauchi et al., 1999). Anti-GFP immunostaining of
E10.5 embryos revealed EGFP-positive (EGFP+) cells in the
DRG, outflow tract of the aorta, optic mesenchyme, gut, and tri-
geminal ganglia (Figures 1B–1F). In adult mice, EGFP+ cells were
observed in the DRG, dermal papilla of whisker follicles, and BM
of the tibia (Figures 1G–1I). As a negative control, we examined
anti-GFP staining in single transgenic P0-Cre mice without the
Floxed-EGFP reporter and detected no EGFP+ cells (data not
shown), confirming the validity of the anti-GFP staining. Immuno-
histochemistry was also performed on various tissues from adult
Wnt1-Cre/Floxed-EGFPmice, confirming thepresenceof EGFP+
cells in the DRG, dermal papilla, and BM (see Figure S1 available
online). These observations suggest that EGFP+ neural crest-
derived cells migrate to and survive in various adult tissues.
Since neural crest-derived cells have not been previously
reported in the BM, we analyzed the distribution of EGFP+ cells
in the BM of P0-Cre/Floxed-EGFP mice by immunohistochemis-
try. It is unlikely that EGFP expression was induced by the
ectopic expression of P0, since we did not detect P0 protein in
the BM (Figure S2). In the BM of P0-Cre/Floxed-EGFP mice,
EGFP+ cells were detected along blood vessels, especially the
vasculature located near the inner surface of the bone cortex
(Figures 2A–2C). In whole-mount specimens, these EGFP+ cells
were positive for both PECAM-1 and SMA, markers for endothe-
lial cells and smooth muscle cells (Figures 2E–2L), and quantita-
tive analysis revealed that 3.85% and 6.23% of the EGFP+ cells
Figure 1. Expression Pattern of EGFP in
P0-Cre/Floxed-EGFP Mice at E10.5 and the
Adult Stage
(A) Whole-body observation of direct EGFP fluo-
rescence in E10.5 mice.
(B–F) Anti-GFP immunostaining of E10.5 mice re-
vealed EGFP+ cells in the DRG (B), outflow tract
of the heart (C), optic mesenchyme (D), gut (E),
and trigeminal ganglion (F).
(G–I) In 8-week-old adult mice, EGFP+ cells were
detected in the DRG (G), dermal papilla in the
whisker follicle (arrow in [H]), and BM of the tibia
(I). Scale bars, 1 mm in (A) and 50 mm in (B)–(I).
in the BMwere positive for PECAM-1 and
SMA, respectively. The contribution of
EGFP+ cells to the vascular endothelial
structure was also confirmed by flow-
cytometric analysis (Figure 2D) and
whole-mount immunohistochemistry with
other vascular markers (Figures 2M–2X).
Although a portion of vascular smooth
muscle cells are known to be derived from the neural crest, neu-
ral crest-derived cells have not been reported in the vascular
endothelium in previous studies (Etchevers et al., 2001; Joseph
et al., 2004). To corroborate our observations, we examined
the BM in adult Wnt1-Cre/Floxed-EGFP mice. Although a similar
number of EGFP+ cells was observed, the EGFP+ cells did not
express endothelial cell or smooth muscle cell markers (Figures
S1C and S1D). Thus, our detailed analyses using two lines of
transgenic mice demonstrated the presence of neural crest-
derived cells in the BM, but their contribution to blood vessel
formation remains unclear.
NCSCs Migrate from the Trunk Dorsal Neural Tube
to the Aorta-Gonad-Mesonephros Region and Circulate
in the Blood during Embryonic Development
To elucidate the migration route of EGFP+ cells from the trunk
dorsal neural tube to the BM, we focused on the aorta-gonad-
mesonephros (AGM) region in P0 and Wnt1-Cre/Floxed-EGFP
mice. During development, the first adult-type hematopoietic
stem cells (HSCs) are generated at E10.5 in the AGM region
andmigrate via the blood stream to the BM in the late embryonic
period (Medvinsky and Dzierzak, 1996; Muller et al., 1994). Mes-
enchymal stem cells (MSCs) are also generated in the AGM
region at E11.0, migrate in the blood stream, and are found in
the neonatal BM (Mendes et al., 2005). We therefore hypothe-
sized that neural crest-derived cells take a similar route to the
BM, migrating from the dorsal neural tube to the AGM region,
from which they then travel through the blood stream to the
BM. Anti-GFP immunostaining revealed EGFP+ cells migrating
from the trunk dorsal neural tube to the AGM region in E11.0
P0-Cre/Floxed-EGFP mice (Figure 3A). These EGFP+ cells
were 100% positive for p75 and 50.6% positive for Sox10,
both known as NCSC markers (Paratore et al., 2001; Stemple
and Anderson, 1992) (Figures 3B and 3C), suggesting that a por-
tion of the EGFP+ cells in the AGM region were NCSCs. At E12.5,
most of the EGFP+ cells were positive for tyrosine hydroxylaseCell Stem Cell 2, 392–403, April 2008 ª2008 Elsevier Inc. 393
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para-aortic plexus (Figure 3D), raising the possibility that
EGFP+ Sox10 cells at E11.0 were neuroblasts that differenti-
ated into TH+ neurons at E12.5. However, the small number of
TH– EGFP+ cells that invaded the aorta were positive for p75
and Sox10 (Figures 3E–3H), suggesting that the cells entering
the blood vessel were NCSCs. None of the EGFP+ cells at the
periphery of aorta were positive for GFAP (Figure 3I), ruling out
the possibility that the EGFP+ cells are newly arrived Schwann
cells that are migrating along the vasculature. EGFP+ p75+ cells
were also observed in peripheral blood at E12.5 by immunohis-
tochemistry (Figures 3J and 3K), and flow-cytometric analysis of
the blood taken from E13.5 to E15.5 mice detected EGFP+ cells
(Figure 3L). In E14.5 mice, immunohistochemistry revealed
EGFP+ Sox10+ cells in the fetal liver (Figures 3M and 3N). After
E18.5, no EGFP+ cells were detected in the circulating blood
(Figure 3L). Similar results were observed in the AGM region, pe-
ripheral blood, and fetal liver in Wnt1-Cre/Floxed-EGFP mice
(Figure S3). These observations suggest that NCSCs migrate in
the blood to the BM via the AGM region, specifically during
E12.5–E15.5, similar to HSCs.
Sphere-Forming Capability of Neural Crest-Derived
Cells from Adult Mice
Tocompareneural crest-derivedcells fromtheDRG,WP, andBM,
cells from these tissues were collected from postnatal 2-, 4-, 8-,
and 13-week-old P0-Cre/Floxed-EGFP mice, and their EGFP
expression was analyzed by flow cytometry. The frequency of
EGFP+ cells from each source was highest at 2 weeks of age
and decreased over time (Figures 4A and 4B). The same result
was observed inWnt1-Cre/Floxed-EGFPmice (Figure S4A). Inter-
estingly, the number of EGFP+ cells collected from the BM
increased when the bones were treated with collagenase. Since
collagenase releases BM cells that adhere tightly to the bone
(Funk et al., 1994), this suggests that the neural crest-derived cells
observed histologically were tightly associated with the BM
surface.
The formation of neurosphere-like spheres from neural crest-
derived tissue has been reported (Fernandes et al., 2004; To-
mita et al., 2005; Yoshida et al., 2006) using culture procedures
similar to neurosphere-culture protocols for cells of the central
nervous system (CNS) (Reynolds and Weiss, 1992). To confirm
the capability of neural crest-derived cells to proliferate and
form spheres, EGFP+ and EGFP cells from the DRG, WP,
and BM of 8-week-old P0-Cre/Floxed-EGFP mice were col-
lected by flow cytometry and cultured at a density of 5 3 103
cells/ml (Hulspas et al., 1997) in serum-free sphere-formingmedium containing human epidermal growth factor (EGF), hu-
man fibroblast growth factor 2 (FGF2), and B27. The EGFP+
cells proliferated to form spheres that were morphologically
similar to CNS neurospheres after 14 days (Figure 4C). When
cultured at the same density, the highest number of spheres
was formed from cells derived from the DRG and the lowest
from the BM (Figure 4D). Cultured EGFP cells derived from
the DRG and BM did not form spheres, but those from the
WP did, albeit at a much lower frequency than the EGFP+ cells
(Figure 4D). Sphere-forming capacity and tissue-specific
sphere-forming efficacy in cells from adult Wnt1-Cre/Floxed-
EGFP mice were similar to those from P0-Cre/Floxed-EGFP
mice (Figures S4B and S4C). These results indicate that neural
crest-derived cells capable of proliferating into spheres exist in
the adult DRG and BM in addition to the WP, which has been
previously reported.
Spheres Derived from Each Adult Tissue Contain
Multipotent NCSCs
Previous reports have characterized NCSCs by their ability to
self-renew and their capacity for multilineage differentiation
(multipotency) into neurons, glial cells, and myofibroblasts
(Morrison et al., 1999; Shah et al., 1996). To evaluate the differ-
entiation potential of EGFP+ spheres generated from sorted
EGFP+ cells, we cultured EGFP+ spheres from the three tissue
sources of adult P0-Cre/Floxed-EGFP mice for 10 days in 10%
serum-containing differentiation medium. The differentiated
cells were identified by triple immunostaining: neurons by b-III
tubulin, glial cells by glial fibrillary acidic protein (GFAP), and
myofibroblasts by SMA. EGFP+ spheres from all three sources
demonstrated trilineage differentiation potential (Figure 5A), but
the differentiation preference differed depending on the tissue
source (Table 1). Most of the DRG-derived spheres showed trili-
neage differentiation potential (NGM, 74.6%), but the frequency
was significantly lower in the WP- and BM-derived spheres
(NGM, 7.3% and 3.3%, respectively). The WP-derived spheres
displayed a bilineage differentiation tendency into neurons and
myofibroblasts (NM, 91.6%), while most BM-derived spheres
differentiated into myofibroblasts (M, 64.6%), suggesting that
EGFP+ cells derived from the WP and BM are mostly lineage-
restricted progenitors, with only a small percentage possessing
multilineage differentiation potential. In addition, when EGFP+
DRG-derived spheres were cultured in differentiation medium
containing 5-bromo-20-deoxyuridine (BrdU) (Figure 5B), all three
resulting cell types (N, M, and G) were positive for BrdU.
Therefore, these three cell types from DRG-derived spheres
probably originated from mitotic precursor cells within theFigure 2. EGFP+ Cells Contribute to Vascular Endothelial and Smooth Muscle Cells in the BM of P0-Cre/Floxed-EGFP Mice
(A–C) EGFP+ cells were detected along vasculature in the tibia.
(D) Representative EGFP- and PECAM-1-gated flow-cytometric analysis chart. To prevent the contamination of macrophages, CD45+ cells were removed before
analysis.
(E–L) Triple immunohistochemistry for GFP, PECAM-1, and SMA inwhole-mount specimens. Note the abundant EGFP+ cells around the inner surface of the bone
cortex (outer surface indicated by dotted lines). (I–L) High-magnification views of the boxed areas in (E)–(H), respectively. Note the EGFP+ endothelial cells
(arrowheads) and smooth muscle cells (arrows).
(M–P) Triple immunohistochemistry forGFP, PECAM-1, andPDGFRb, amarker for pericytesand smoothmuscle cells. Thearrowhead indicatesEGFP+PECAM-1+
endothelial cells.
(Q–T) EGFP+ cells were also positive for VE-cadherin, a marker for endothelial cells (arrowheads).
(U–X) In triple-transgenic mice encoding P0-Cre/Floxed-EGFP/Flt1lacZ, EGFP+ cells were positive for PECAM-1 and b-gal (arrowheads). Flt1 is expressed in
endothelial and hematopoietic cells. Scale bars, 50 mm in (A)–(C), 200 mm in (E)–(H), and 20 mm in (I)–(X).Cell Stem Cell 2, 392–403, April 2008 ª2008 Elsevier Inc. 395
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(A) At E11.0, EGFP+ cells detected by anti-GFP antibodies were seenmigrating from the dorsal neural tube into the AGM region. The region enclosed in a dashed
line with an asterisk indicates the aorta.
(B and C) Double immunohistochemistry of the AGM region revealed that EGFP+ cells were positive for p75 (B) and partially colocalized with Sox10 (C), indicating
that EGFP+ cells in the embryonic AGM region expressed NCSC markers.
(D–F) At E12.5, most EGFP+ cells had differentiated into TH-positive catecholaminergic neurons (D), but some EGFP+ TH cells invaded the aorta (arrows in [E]
and [F]).396 Cell Stem Cell 2, 392–403, April 2008 ª2008 Elsevier Inc.
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Floxed-EGFP Mice
(A) Representative EGFP-gated flow-cytometric analysis charts of cells from the DRG, WP, and BM of postnatal 2-, 4-, 8-, and 13-week-old mice. In the BM, the
number of collected EGFP+ cells increased with collagenase treatment.
(B) The number of collected EGFP+ cells from all three sources decreased with age (mean ± SEM, n = 3 per group).
(C) Phase-contrast and direct EGFP-fluorescent images showing spheres formed from EGFP+ cells after 14 days in culture. Scale bar, 50 mm.
(D) The percentage of sphere-forming cells found in each tissue source was assessed by culturing EGFP+ and EGFP cells from each source at a cell density of
53 103 cells/ml and counting the number of spheres formed (mean ± SEM; n = 3 per group; **p < 0.01; y, no sphere observed). The highest percentage of sphere-
forming cells was observed in the DRG, and the WP was the only source with EGFP cells capable of forming spheres.spheres and did not represent contamination of postmitotic cells
from the original tissue.
Recent reports have questioned the validity of ‘‘clonal density’’
cultures (Jessberger et al., 2007; Singec et al., 2006), demon-
strating that CNS neurospheres are motile structures that can
fuse even at cellular concentrations previously regarded as
‘‘clonal’’ (Hulspas et al., 1997). To assess the possible effects
of sphere fusion in our culture protocol, we examined the
differentiation of spheres cultured in medium containing 0.8%
methylcellulose (Figures S5A–S5C). This method, which we pre-
viously reported (Yoshida et al., 2006), effectively prevents
sphere fusion, resulting in spheres that are more than 90%
clonal. Differentiation studies of these clonal spheres yielded
results similar to those shown in Table 1 (Figure S5D), indicatingthat the influence of sphere fusionwas quite limited. Results from
adultWnt1-Cre/Floxed-EGFPmice corroborated data from adult
P0-Cre/Floxed-EGFP mice, revealing the formation of clonal
spheres from the DRG, WP, and BM that possessed a similar
differentiation preference (Figures S4B–S4E).
To assess the self-renewal capacity of the EGFP+ spheres,
secondary sphere-forming assays were conducted. EGFP+
spheres derived from each tissue source of P0-Cre/Floxed-
EGFP mice were independently placed into one well of
a 96-well plate, dissociated into single cells, and cultured in
sphere-forming medium. The frequency of secondary sphere
formation was highest in cells derived from the DRG
(Figure 5C), confirming that, of these three sources, the DRG
contains the highest frequency of NCSCs.(G–I) At E12.5, most EGFP+ cells at the periphery of the aorta were positive for p75 and Sox10 but negative for GFAP.
(J and K) EGFP+ p75+ cells were observed in the peripheral blood of E12.5 mice (boxed area in [J] magnified in [K]).
(L) EGFP-gated flow-cytometric analysis charts of embryonic and postnatal blood cells. EGFP+ cells were detected fromE13.5 and E15.5, but not at E18.5 or after
birth. Transverse axis indicates forward scatter (FSC).
(M andN) At E14.5, EGFP+ cells were observed in the liver. Somewere positive for Sox10, indicating that NCSCs exist in the liver. Scale bars, 100 mm in (A)–(F), (J),
and (M); 50 mm in (G)–(I), and (N); and 20 mm in (K).Cell Stem Cell 2, 392–403, April 2008 ª2008 Elsevier Inc. 397
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Differs among Tissue Sources
To characterize themRNA expression profile of neural crest cells
derived from each tissue, cells from the adult P0-Cre/Floxed-
Figure 5. Differentiation and Secondary
Sphere-Forming Capacity of EGFP+
Spheres Derived from the DRG, WP, and
BM in Adult P0-Cre/Floxed-EGFP Mice
(A) EGFP+ spheres formed from each tissue
source differentiated into neurons, glial cells, and
myofibroblasts. Scale bars, 50 mm.
(B) DRG-derived spheres were cultured in medium
containing BrdU. Cells double positive for BrdU
and each cell-type-specific marker were ob-
served. Scale bar, 25 mm.
(C) When these spheres were dissociated, the
DRG-derived cells formed the greatest number
of secondary spheres, indicating their high capac-
ity for self-renewal (mean ± SEM; n = 3 per group;
*p < 0.05).
EGFP mice were analyzed by semiquan-
titative RT-PCR for various markers, es-
pecially neural crest-associated genes
(Figure 6A). The following were prepared
from each adult tissue source: noncul-
tured EGFP and EGFP+ cells, cultured
spheres, and cells differentiated from
spheres. The noncultured cells showed
varying tissue-source-dependent gene
expression patterns. EGFP+ cells from
the DRG strongly expressed the known
NCSC markers Sox10 and p75. Although
their expression of the neural crest
markers Snail, Slug, Twist, Sox9, and
Pax3 was lower or undetectable com-
pared to EGFP cells, most of these
markers were expressed after culture.
The expression of neural crest-associ-
ated genes was quite similar in EGFP+
and EGFP cells from the WP, whereas
in the BM, their expression was
significantly higher in EGFP+ cells com-
pared to EGFP cells.
For the EGFP+ spheres, although the
expression frequencies of neural crest-
associated genes differed, the spheres
from all three tissues generally expressed
most of the neural crest-associated
genes. By comparison, CNS neuro-
spheres derived from the E14.5 striatum
did not express the neural crest-associ-
ated genes Snail, Slug, Twist, p75, or
Pax3. They expressed sox9 and sox10
as expected, since these genes are also
deeply involved in development of the
CNS (Stolt et al., 2003, 2004). Nkx6.1 is
a well-known marker expressed in the
ventral half of the neural tube during early development (Jensen
et al., 1996). EGFP+ cells and spheres did not express Nkx6.1, in
contrast to its strong expression in embryonic stem cell-derived
neurospheres ventralized by the sonic hedgehog protein (Shh)398 Cell Stem Cell 2, 392–403, April 2008 ª2008 Elsevier Inc.
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Frequency of Sphere Types (Percent ± SD)
NGM NM NG GM N M G Others
DRG 74.6 ± 1.0 21.8 ± 3.6 2.3 ± 3.2 0 1.0 ± 0.2 0 0 0
WP 7.3 ± 3.6 91.6 ± 3.1 0 0 0 1.1 ± 1.1 0 0
BM 3.3 ± 0.4 15.6 ± 0.8 0.5 ± 0.8 0.8 ± 0.7 7.3 ± 8.5 64.6 ± 11.7 0.7 ± 1.2 7.3 ± 2.6
EGFP+ spheres formed from clonal density cultures of each tissue source were differentiated and subjected to triple immunostaining. The differenti-
ation potential of 100 spheres from each tissue source was individually examined, and each sphere’s ability to differentiate into each cell type was
determined: N, neurons; G, glial cells; M, myofibroblasts (mean ± SD, n = 3 per group). Spheres derived from the DRG showed a significantly higher
frequency of trilineage differentiation potential (N + G +M) than the spheres from other sources (p < 0.05 by Kruskal-Willis test). Of the spheres derived
from the BM, 7.3% were negative for all three lineage markers.(Y.O. and H.O., unpublished data). These results indirectly sug-
gest that the examined cells did not have ventral identities and
do not conflict with the fact that they are developmentally de-
rived from the dorsal neural tube, where neural crest cells origi-
nate.
EGFP+ Cells of the DRG Strongly Express NCSCMarkers
in Adult P0-Cre/Floxed-EGFP Mice
To quantify the expression of the NCSC markers Sox10 and p75
in fresh noncultured EGFP+ cells and in spheres cultured for 2
weeks, we performed real-time PCR (Figure 6B). Sox10 and
p75 expression was higher in both the noncultured cells and cul-
tured spheres from the DRG compared with those from the WP
and BM, suggesting that there is a higher proportion of NCSCs
in the DRG. However, since these genes are also expressed in
specific neurons and glial cells (Kaplan andMiller, 2000; Paratore
et al., 2001), we examined the expression levels of Nestin and
Musashi1. Although they are used asmarkers for undifferentiated
cells in the CNS (Lendahl et al., 1990; Sakakibara et al., 1996),
they are also expressed in neural crest-derived sphere initiating
cells from the heart (Tomita et al., 2005), cornea (Yoshida et al.,
2006) and gut (R. Hotta, S.S., and H.O., unpublished data). Since
it has been suggested that Nestin andMusashi1 expression may
reflect an undifferentiated state (Tomita et al., 2005), their high
expression in spheres generated from the DRG also suggests
that theDRGcontains the highest proportion of NCSCs, and their
increased expression after culture suggests that these NCSCs
proliferate in culture when spheres are formed.
DISCUSSION
In the present study, by using the double-transgenic mouse
strains P0 and Wnt1-Cre/Floxed-EGFP, we examined multiple
tissues and organs to map the presence of neural crest-derived
cells. We discovered the existence of multipotent NCSCs in the
BM and DRG of adult rodents along with the previously reported
facial WP. However, analysis of these cells revealed interesting
differences that were specific to the tissue source. Careful con-
sideration of these differences will be necessary if these cells are
to be recruited for cell transplantation treatments.
Our histological analysis of adult P0 and Wnt1-Cre/Floxed-
EGFP mice revealed EGFP+ cells in the BM (Figure 1 and
Figure S1). Using flow cytometry, we collected EGFP+ BM cells
that proliferated to form spheres (Figure 4). Although the
frequency was low, compared with the other tissue sources,multipotent NCSCs were present in the BM. Clonal spheres
with a trilineage differentiation potential into neurons, glial cells,
and myofibroblasts were observed, and dissociated cells from
these spheres formed secondary spheres (Figure 5, Figures S4
and S5). The presence of NCSCs in the BM is also supported
by a recent report using the same P0-Cre reporter mice to dem-
onstrate that a portion ofMSCs in the BMof the lower extremities
are of neural crest lineage (Takashima et al., 2007). Furthermore,
we have unpublished data showing that NCSCs contribute to
produce a subpopulation of MSCs in the BM. At the embryonic
stage, NCSCs differentiate into many types of neural crest
lineage cells, most of which are marked with EGFP in P0 and
Wnt1-Cre/Floxed-EGFP mice. We prospectively isolated
EGFP+ MSCs from the BM of P0 and Wnt1-Cre mice using
flow cytometry and identified that EGFP+ MSCs could generate
osteocytes, chondrocytes, and adipocytes (S.M. and Y.M.,
unpublished data). Together with Nishikawa’s report, these find-
ings show that a certain population of MSCs in the BM originates
from multipotent NCSCs.
Since a previous report indicated thatWnt1 is expressed in the
BM of adult rodents (Almeida et al., 2005), we cannot rule out the
possibility that the EGFP+ labeling in the BM of adult Wnt1-Cre/
Floxed-EGFPmicewas due to the ongoing expression ofWnt1 in
the adult BM rather than reflecting a history of Wnt1 expression
in the embryonic neural crest lineage. However, we found that
the sphere-forming potential and differentiation tendency of
EGFP+ cells from the BM of Wnt1-Cre/Floxed-EGFP mice were
similar to those fromP0-Cre/Floxed-EGFPmice (Figure S4), sug-
gesting the presence of NCSCs among the EGFP+ cells in the
BM of adult Wnt1-Cre/Floxed-EGFP mice. The BM stem cells
reported in other studies differentiated into neurons and glial
cells in vitro and in vivo and also in transplantation experiments
(Fernandez et al., 2004; Jiang et al., 2002). Although transdiffer-
entiation or dedifferentiation has been suggested to explain this
phenomenon, our results demonstrating the presence of NCSCs
in the BM indicate that this differentiation potential may reflect
that of NCSCs of the BM. It will be interesting to clarify the rela-
tionship between the NCSCs described in the present study and
the BM-derived stem cells that are reported to generate neural
cells in vitro (Kohyama et al., 2001).
Hematopoiesis is initiated in the yolk sac at the embryonic
stage and is successively transferred to the AGM region, fetal
liver, and BMwith time (Dzierzak and Speck, 2008). Using two in-
dependent Cre lines, we detected NCSCs in the AGM region, fe-
tal liver, and BM during a time frame that coincided with theCell Stem Cell 2, 392–403, April 2008 ª2008 Elsevier Inc. 399
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join the migration pathway of hematopoietic cells on the way to
the BM from the embryonic period through adulthood. Our pres-
ent findings concerning the migration stream of NCSCs imply an
undiscovered relationship between NCSCs and hematopoiesis.
The DRG is derived from the neural crest. Although several
groups have demonstrated the existence of NCSCs in the em-
bryonic DRG (Leimeroth et al., 2002; Paratore et al., 2001), we
confirmed their existence in the DRG of adult rodents. Recently,
DRG-derived sphere-initiating cells were reported in adult
rodents, but their origin and potential were not elucidated (Li
et al., 2007). In our present study, using P0 and Wnt1-Cre re-
porter mice, we demonstrated that the observed cells were of
neural crest lineage. Furthermore, examination of the spheres
formed through a valid clonal culture method confirmed the
presence of cells with stem cell-like properties in the DRG of
Figure 6. Expression Patterns of Embryonic
Neural Crest-Specific Markers in Adult
P0-Cre/Floxed-EGFP Mice
(A) Semiquantitative RT-PCR was conducted to
evaluate the mRNA expression of various NCSC
markers. Four types of cells were examined for
each tissue source: EGFP and EGFP+ cells
freshly fractionated by flow cytometry, EGFP+
spheres after 14 days in culture, and differentiated
cells. Total RNA from a whole E11.5 embryo was
collected as a positive control. The expression fre-
quencies of neural crest-lineage markers from the
three tissue sources were variable and quite differ-
ent from the CNS-type neurospheres cultured
from the striatum of an E14.5mouse (CNS sphere).
The ventral marker Nkx6.1, observed in ES-cell-
derived neurospheres ventralized by Shh induc-
tion, was not observed in any of the EGFP+ neural
crest-derived spheres.
(B) Quantitative PCR analysis revealed signifi-
cantly higher expression of the NCSC markers
Sox10 and p75 in the cells derived from the adult
DRG. Immature stem/progenitor specific markers
Nestin and Musashi1 were also highly expressed
in the DRG-derived spheres. *p < 0.05, **p < 0.01.
adult mice. Compared with the cells de-
rived from the WP and BM, the neural
crest-derived cells of the DRG contained
a higher proportion of tripotent cells and
displayed a greater ability to form sec-
ondary spheres (Figure 5 and Table 1).
The expression levels of the NCSC
markers Sox10 and p75, and markers
for undifferentiated stem/progenitor
cells, Nestin and Musashi1, were also
higher in the DRG-derived EGFP+ cells
from adult P0-Cre/Floxed-EGFP mice
(Figure 6B), suggesting that the DRG
contained the highest proportion of
NCSCs of the tissues studied. The origin
of the NCSCs in the DRG is presently un-
known. The DRG develops from two
sources: neural crest cells that follow the ventromedial pathway
and BC cells that originate from the dorsal root entry zone (Maro
et al., 2004). BC cells are also neural crest-derived populations
that transiently occupy the dorsal entry and ventral exit points
of trunk spinal nerve roots during peripheral nervous system de-
velopment (Altman and Bayer, 1984; Niederlander and Lums-
den, 1996). Since embryonic BC cells include multipotent
NCSCs (Hjerling-Leffler et al., 2005), it is possible that NCSCs
originating from the BC migrate to and remain in the DRG until
adulthood.
The presence of NCSCs in the facial skin and whisker follicle
was reported previously (Fernandes et al., 2004; Sieber-Blum
et al., 2004), and our results confirm their existence. An interest-
ing finding was the formation of spheres from EGFP cells of the
WP of P0 andWnt1-Cre/Floxed-EGFPmice, although at a signif-
icantly lower percentage than the EGFP+ cells (Figure 4D and400 Cell Stem Cell 2, 392–403, April 2008 ª2008 Elsevier Inc.
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genitor cells with an origin other than the neural crest, such as the
keratinocyte stem cells of the epithelium (Kobayashi et al., 1993).
However, since the gene expression profile of EGFP cells was
similar to that of EGFP+ cells, this seems unlikely (Figure 6A). An-
other possible explanation for their presence is transgene silenc-
ing through epigenetic modifications such as DNA methylation,
which can weaken EGFP expression (Turker, 2002). When
EGFP spheres were cultured in medium containing the deme-
thylating agent 5-azacytidine, we observed EGFP expression
in some of them (data not shown), suggesting that DNA methyl-
ation-mediated transgene silencing partially accounts for the
presence of EGFP spheres.
Our results from culturing and characterizing NCSCs from the
adult BM, DRG, and WP revealed significant tissue-source-de-
pendent differences. Similarly, NCSCs from the embryonic gut
and sciatic nerve exhibit heritable, cell-intrinsic differences in
their responses to lineage-determination factors in vitro and
in vivo (Bixby et al., 2002). Factors that come into play during
the segregation, migration, andmaintenance of neural crest cells
have been proposed to explain these differences in NCSC char-
acteristics. In the premigratory neural tube, a gradient of multiple
signals is present along the rostrocaudal neuraxis, affecting the
premigratory neural crest cells (Abzhanov et al., 2003; Lwigale
et al., 2004). Once the neural crest cells separate from the neural
tube, they are exposed to amultitude of factors through their path
of migration, and NCSCs that survive in each respective tissue
are affected by factors within that tissue (Couly et al., 2002;
Trainor et al., 2002). There are also differences between embry-
onic and postnatal stages, as revealed in a study showing differ-
ences between fetal and adult gut NCSCs (Kruger et al., 2002).
Therefore, itmay be unrealistic to attempt to characterizeNCSCs
as a single population, since those from different sources display
different traits. Instead, it will be important to understand these
differences and to elucidate the molecular mechanisms for the
maintenance and lineage determination of NCSCs in each tissue.
NCSCs are attracting increasing interest as potential candi-
dates for cell transplantation therapy of nerve trauma and dis-
ease, because they are present in tissue that can be harvested
from the patient. This allows for autologous transplantation,
avoiding immunological complications as well as the ethical
concerns associated with embryonic stem cells. We isolated
and examined NCSCs from adult tissues with this in mind and
discovered that NCSCs from different tissues had distinct char-
acteristics. Further study of these NCSCs will hopefully lead to
the culture and transplantation of NCSCs most appropriate for
the lesion receiving treatment.
EXPERIMENTAL PROCEDURES
Animals
Transgenic mice expressing Cre recombinase under control of the P0
promoter (P0-Cre) (Yamauchi et al., 1999) and Wnt1 promoter/enhancer
(Wnt1-Cre) (Danielian et al., 1998) were mated with EGFP reporter mice
(CAG-CATloxP/loxP-EGFP) (Kawamoto et al., 2000) to obtain P0-Cre/Floxed-
EGFP and Wnt1-Cre/Floxed-EGFP double-transgenic mice. Mice heterozy-
gous for a null allele of Flt1 (Flt1+/lacZ) (Fong et al., 1995) were crossed to
P0-Cre/Floxed-EGFP double-transgenic mice to obtain P0-Cre/Floxed-
EGFP/Flt1lacZ triple transgenic mice. Adult wild-type mice were purchased
for mating from CLEA Japan. All experimental procedures were approved bythe ethics committee of Keio University andwere in accordance with the Guide
for the Care and Use of Laboratory Animals (U.S. National Institutes of Health).
Immunohistochemistry
For histological analysis, samples were fixed in 4% paraformaldehyde (PFA)
and embedded in cryomold for sectioning at 14 mm. The following antibodies
were used as primary antibodies: anti-green fluorescent protein (GFP) (rabbit
IgG, 1:500, MBL, and goat IgG, 1:200, Santa Cruz Biotechnology), Sox10
(goat IgG, 1:200, R&D Systems), p75 (rabbit IgG, 1:500, Chemicon), TH (sheep
IgG, 1:200, Chemicon), and P0 (chick IgG, 1:200, Aves). Immunoreactivity was
visualized using secondary antibodies conjugated with Alexa 488 or Alexa 568
(Molecular Probes). Nuclear counterstaining was performed with Hoechst
33342 (10 mg /ml, Sigma B2261). The samples were observed with a confocal
laser scanning microscope (LSM510, Carl Zeiss). Whole-mount preparation of
tibias and immunostaining were performed as described (Kubota et al., 2008).
Preparation of DRG, WP, and BM Cells
Juvenile (14–28 days) and adult (2–12 months) P0-Cre/Floxed-EGFP mice
were deeply anesthetized and sacrificed by cervical dislocation.
DRG
The vertebral body was dissected out, and the DRGs from C5 to L5 were
resected into HBSS+ (GIBCO 14025-092) supplemented with 10% fetal bovine
serum (FBS; Equitech-Bio SFB30-1478) and 1% penicillin/streptomycin (P/S;
GIBCO-BRL). The peripheral nerve tissue was removed, and the DRGs were
incubated with 0.25% collagenase (Sigma C5894) in HBSS+ for 30 min at
37C. After being rinsed in PBS, the DRGs were incubated in 0.25% trypsin-
EDTA for 30 min at 37C and mechanically dissociated into DRG medium
(neurobasal medium [GIBCO 21103-049] supplemented with 20 ng/ml B27
[GIBCO], 1% L-glucose [GIBCO], and 1% P/S). The cells were collected by
centrifugation at 800 3 g for 3 min at 4C.
WP
The facialWPwas carefully dissected, washed in HBSS, and incubated in 0.3%
dispase II (Roche 1276921) in DMEM-F12 (GIBCO 11330-032) containing 1%
P/S for 3 hr at 37C. Hair and dermis were removed with a cell lifter (Costar).
The skin tissue wasminced into small pieces and digested with 0.04%collage-
nase (Wako 038-10531) in DMEM-F12 for 1 hr at 37C. Cell clusters were
mechanically dissociated in medium, and the suspension was poured through
a 70 mm cell strainer (Falcon). The dissociated cells were collected by centrifu-
gation at 4803 g for 3 min at 4C.
BM
The femurs and tibias were dissected out and crushed with a pestle. The
crushed bones were washed in HBSS+ (GIBCO 14175-095) supplemented
with2%FBS,10mMHEPES (GIBCO15630-080), and1%P/S to removehema-
topoietic cells. The bone fragments were collected and incubated for 1 hr at
37C in 0.2% collagenase (Wako 032-10534) in DMEM (GIBCO 11885-084)
containing 10 mM HEPES and 1% P/S. The suspension was filtered with
a cell strainer (Falcon 2350) and collected by centrifugation at 280 3 g for 7
min at 4C. The pellet was resuspended for 5–10 s in 1 ml water (Sigma
W3500) to burst red blood cells, after which 1ml of 23PBS (diluted fromSigma
D1408) containing 4%FBSwas added. The cells were resuspended in HBSS,
and the suspension was poured through a cell strainer.
Flow-Cytometric Analysis
Flow-cytometric analysis was performed as described previously (Matsuzaki
et al., 2004). For detailed analysis of the BM in P0-Cre/Floxed-EGFP mice,
BM cells were stained for 30 min on ice with PE-anti-PECAM-1 and APC-
anti-CD45 (eBioscience, CA). After collecting 13 105 events, the fluorescence
intensity of PECAM-1 and EGFP in the CD45-negative cell population was
plotted as a two-dimensional dot plot.
Blood cells from embryoswere obtained by cutting the umbilical arteries and
allowing the blood to flow freely into PBS. After collecting the PBS, EGFP+ cells
were identified by EGFP fluorescence.
Primary and Secondary Sphere-Forming Cultures
Cells from the DRG, WP, and BM were seeded at 5 3 103 cells/ml (Hulspas
et al., 1997) in a serum-free sphere-forming medium consisting of DMEM/
F-12 (1:1) (GIBCO 12100-046/21700-075) supplemented with insulin
(25 mg/ml), transferrin (100 mg/ml), progesterone (20 nM), sodium selenate
Cell Stem Cell
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(100 ng/ml) (Pepro Tech #100-15), human FGF-basic (100 ng/ml) (Pepro Tech
#100-18b), and B27 (20 ng/ml) (modified from Reynolds and Weiss [1992]).
Cells were cultured in an incubator at 37C, 5% CO2, and half of the medium
was changed every 6–7 days. For BrdU labeling, 1 mMBrdU was added to the
culture medium every 3 days. For clonal sphere expansion, the cells were
cultured in the above medium with 0.8% methylcellulose (nacalai tesque
22224-55) (Yoshida et al., 2006).
For secondary sphere formation assays, primary spheres were collected,
incubated in 0.25% trypsin-EDTA for 30 min at 37C, and triturated until a sin-
gle-cell suspension was obtained. The cells were spun at 860 3 g for 3 min at
4C and resuspended in the aforementioned sphere culture medium.
For statistical evaluation of the primary and secondary sphere-forming
assays, one-factor ANOVA and the Tukey-Kramer test were applied.
Differentiation Analysis
Spheres were plated on poly-D-lysin/laminin (Sigma P7405/Invitrogen 23017-
015)-coated 8-well chamber slides (Iwaki 5732-008) and cultured for 10 days in
the following differentiationmedium: DMEM/F12 (1:1) supplemented with 10%
FBS, without any growth factors. For immunocytochemistry, the cells were
fixed in 4% PFA and stained with the following primary antibodies: anti-
GFAP (rabbit IgG, 1:500, Dako Z0334), b-III tubulin (mouse IgG2b, 1:500,
Sigma T8660), aSMA (mouse IgG2a, 1:1000, Sigma A2547), and BrdU (sheep
IgG, 1:500, Fitzgerald 20-BS17). Secondary antibodies were the following:
anti-mouse IgG2b (Alexa 488 A-21141), anti-mouse IgG2a (Alexa 350
A-21130), anti-rabbit IgG (Alexa 568 A11036), and anti-sheep IgG (Alexa 568
A-21099 [1:1000, Molecular Probes]). The samples were observed with a
universal fluorescence microscope (Axioskop 2 Plus; Carl Zeiss).
RT-PCR Assay
RT-PCR assay is described in the Supplemental Experimental Procedures. For
statistical analysis, real-time RT-PCR results were evaluated using Student’s
t test.
SUPPLEMENTAL DATA
Supplemental Data include five figures, Supplemental Experimental Proce-
dures, and Supplemental References and can be found with this article online
at http://www.cellstemcell.com/cgi/content/full/2/4/392/DC1/.
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